MediWound Ltd. (MDWD)
NASDAQ: MDWD · Real-Time Price · USD
13.19
+0.07 (0.53%)
Aug 21, 2026, 12:25 PM EDT - Market open
MediWound Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -20.18 | -23.88 | -30.22 | -6.72 | -19.6 | -13.55 |
Depreciation & Amortization | 1.89 | 1.86 | 1.48 | 1.3 | 1.27 | 1.24 |
Stock-Based Compensation | 2.8 | 3.11 | 3.14 | 1.94 | 1.95 | 1.67 |
Other Operating Activities | -12.27 | -1.98 | 10.71 | -9.33 | 11.74 | 1.56 |
Change in Accounts Receivable | 3.35 | 3.21 | -1.14 | 5.66 | -7.58 | 0.93 |
Change in Inventory | -0.24 | -1.36 | 0.19 | -0.91 | -0.72 | 0.26 |
Change in Accounts Payable | 1.51 | 2.35 | 0.41 | -0.59 | 0.41 | 1.72 |
Change in Unearned Revenue | 0.72 | - | 1.18 | - | - | - |
Change in Other Net Operating Assets | 0.29 | 0.57 | 0.64 | -1.82 | 0.65 | -2.75 |
Operating Cash Flow | -22.14 | -16.12 | -13.62 | -10.47 | -11.89 | -8.92 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -6.39 | -5.51 | -6.27 | -6.46 | -0.56 | -0.49 |
Investment in Securities | 0.58 | -14.04 | -4.38 | -29.8 | - | 4 |
Other Investing Activities | 1.67 | 1.59 | 2.25 | 1.95 | 0.07 | 0.04 |
Investing Cash Flow | -4.15 | -17.95 | -8.4 | -34.32 | -0.48 | 3.55 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | -1.21 | -0.93 | -0.78 | -0.7 | -0.69 |
Net Debt Issued (Repaid) | -1.38 | -1.21 | -0.93 | -0.78 | -0.7 | -0.69 |
Issuance of Common Stock | 30.98 | 31.05 | 23.38 | 24.91 | 38.39 | 0 |
Other Financing Activities | -0.18 | -0.21 | -3.05 | -1.21 | -1.93 | -0.36 |
Financing Cash Flow | 29.41 | 29.62 | 19.39 | 22.92 | 35.76 | -1.05 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 0.15 | 0.1 | -0.08 | -0.16 | -0.55 | 0.09 |
Net Cash Flow | 3.29 | -4.36 | -2.71 | -22.03 | 22.85 | -6.33 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -28.53 | -21.63 | -19.9 | -16.93 | -12.44 | -9.41 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -240.47% | -127.52% | -98.39% | -90.60% | -46.95% | -39.58% |
Free Cash Flow Per Share | -2.30 | -1.90 | -2.00 | -1.88 | -2.49 | -2.42 |
Levered Free Cash Flow | -29.05 | -15.58 | -6.59 | -3.05 | -8.82 | -1.36 |
Unlevered Free Cash Flow | -29.05 | -15.19 | -6.27 | -2.88 | -8.76 | -1.28 |